Comprehensive Reporting in Cost-Effectiveness Modeling Reply

被引：0
|
作者：
Kohn, Christine G. [1 ,2 ]
Zeichner, Simon B. [3 ]
Chen, Qiushi [4 ]
Montero, Alberto J. [5 ]
Goldstein, Daniel A. [3 ,6 ]
Flowers, Christopher R. [3 ]
机构：
[1] Univ Connecticut, Hartford Hosp, Evidence Based Practice Ctr, Hartford, CT 06112 USA
[2] Univ St Joseph, Sch Pharm, Hartford, CT 06117 USA
[3] Emory Univ, Winship Canc Ctr, Atlanta, GA 30322 USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Cleveland Clin, Cleveland, OH 44106 USA
[6] Rabin Med Ctr, Petah Tiqwa, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 26期
关键词：
IMMUNE-RELATED RESPONSE; ADVANCED MELANOMA; UNTREATED MELANOMA; SOLID TUMORS; NIVOLUMAB; IPILIMUMAB; PEMBROLIZUMAB; MONOTHERAPY; GUIDELINES; CRITERIA;
D O I：
10.1200/JCO.2017.74.5273
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Psychotherapy Is Worth It: A Comprehensive Review of the Cost-Effectiveness
    Margison, Frank
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2011, 198 (02) : 160 - 161
  • [42] Modeling and Cost-Effectiveness in HIV Prevention
    Margo M. Jacobsen
    Rochelle P. Walensky
    [J]. Current HIV/AIDS Reports, 2016, 13 : 64 - 75
  • [43] Modeling and Cost-Effectiveness in HIV Prevention
    Jacobsen, Margo M.
    Walensky, Rochelle P.
    [J]. CURRENT HIV/AIDS REPORTS, 2016, 13 (01) : 64 - 75
  • [44] Cost-effectiveness of media reporting guidelines for the prevention of suicide
    Flego, Anna
    Reifels, Lennart
    Mihalopoulos, Cathrine
    Bandara, Piumee
    Page, Andrew
    Fox, Tina
    Skehan, Jaelea
    Hill, Nicole T. M.
    Krysinska, Karolina
    Andriessen, Karl
    Schlichthorst, Marisa
    Pirkis, Jane
    Le, Long Khanh-Dao
    [J]. SUICIDE AND LIFE-THREATENING BEHAVIOR, 2022, 52 (05) : 1048 - 1057
  • [45] Consensus statement: Recommendations for reporting cost-effectiveness analyses
    Siegel, JE
    Weinstein, MC
    Russell, LB
    Gold, MR
    [J]. PEDIATRIC AIDS AND HIV INFECTION-FETUS TO ADOLESCENT, 1997, 8 (02): : 130 - 134
  • [46] Cost-effectiveness analysis in the United States - Reply
    Pearson, SD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (23): : 2722 - 2723
  • [47] Cost-effectiveness of Statin Therapy for ASCVD Reply
    Pandya, Ankur
    Weinstein, Milton C.
    Gaziano, Thomas A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (20): : 2191 - 2192
  • [48] The negative side of cost-effectiveness analysis - Reply
    Obenchain, RL
    Sacristan, JA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24): : 1932 - 1933
  • [49] Cost-effectiveness of newer antiplatelet drugs - Reply
    Bhatt, D
    Jneid, H
    Corti, R
    Badimon, J
    Fuster, V
    Francis, G
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (20) : 2534 - 2534
  • [50] Updated Recommendations for Cost-effectiveness Studies Reply
    Sanders, Gillian D.
    Neumann, Peter J.
    Russell, Louise B.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (01): : 90 - 90
12345